Boehringer Ingelheim (Canada) Ltd et al. v Laboratoire Riva Inc.
2022
T-197-23
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,732,803 (linagliptin).
Counsel to:
Laboratoire Riva Inc.
The decision is reported
here.